In a previous study, a YM155-adapted subline of the neuroblastoma cell line UKF-NB-3 was characterized by increased cellular ABCB1 levels, decreased SLC35F2 and survivin levels, and a TP53 mutation [16]. The gene discussed is BIRC5; the disease is neuroblastoma.